cro.directory
← Compare landing

Lonza Cell & Gene Technologies vs Dermatology CRO | Medpace

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/lonza/medpace

CategoryLonza Cell & Gene TechnologiesDermatology CRO | Medpace
Listed sitebothcro
SummaryLonza Cell & Gene Technologies provides CDMO services. Headquartered in CH.Dermatology CRO | Medpace provides CRO services. Discovery_source:brave.
Services
  • Regulatory Affairs
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Analytical Method Development & Validation
  • Protein Engineering
  • Cell-Line Development
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Device & Combination Product Services
  • CNS Specialty Services
  • China NMPA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
  • Virology Services
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Microbiology Services
  • Clinical Imaging Core Lab
  • Bioanalysis
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Central Laboratory Services
  • Regulatory Affairs
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Clinical Trial Services
  • Phase IV / Post-Marketing
  • Phase III Clinical Trials
  • Phase II Clinical Trials
  • Phase I Clinical Trials
  • Clinical Operations
Modalities
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Radiopharmaceutical
  • Vaccine
  • Cell Therapy
  • Gene Therapy
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Small Molecule
IndicationsData not yet provided.
  • Women's Health
  • Rare Disease
  • Respiratory
  • Ophthalmology
  • Neurology
  • Nephrology
  • Infectious Disease
  • Immunology
  • Oncology
  • Gastroenterology
  • Metabolic
  • Dermatology
  • Cardiovascular
LocationsData not yet provided.
  • Mexico, Mexico City, Mexico City, Mexico
  • Madrid, Madrid, Spain
  • Dallas, Dallas, TX, USA
  • Johannesburg, Johannesburg, Gauteng, South Africa
  • Warsaw, Warsaw, Masovian, Poland
  • Rotterdam, Rotterdam, South Holland, Netherlands
  • Maastricht, Maastricht, Limburg, Netherlands
  • London, London, England, United Kingdom
  • Milan, Milan, Lombardy, Italy
  • Rehovot, Rehovot, Central, Israel
  • Budapest, Budapest, Budapest, Hungary
  • Munich, Munich, Bavaria, Germany
  • Lyon, Lyon, Auvergne-Rhône-Alpes, France
  • Copenhagen, Copenhagen, Copenhagen, Denmark
  • Prague, Prague, Prague, Czech Republic
  • Leuven, Leuven, Flemish Brabant, Belgium
  • Mexico City, Mexico City, Distrito Federal, Mexico
  • Denver, Denver, CO, USA
  • Dallas, Irving, TX, USA
  • Headquarters, Cincinnati, OH, USA
  • Central Laboratory, Cincinnati, Ohio, United States
  • Central Laboratories, Cincinnati, Ohio, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.